These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8926049

  • 1. Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.
    Hilger RA, Köller M, König W.
    Inflammation; 1996 Feb; 20(1):57-70. PubMed ID: 8926049
    [Abstract] [Full Text] [Related]

  • 2. Effect of the PAF-receptor antagonist SM-12502 on human platelets.
    Köller M, Hilger RA, König W.
    Inflammation; 1996 Feb; 20(1):71-85. PubMed ID: 8926050
    [Abstract] [Full Text] [Related]

  • 3. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
    Moilanen E, Kirkkola AL, Kankaanranta H, Nieminen MM, Vapaatalo H.
    Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
    [Abstract] [Full Text] [Related]

  • 4. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H, Imanishi N, Natsume Y, Morooka S.
    Eur J Pharmacol; 1994 Nov 15; 269(3):299-309. PubMed ID: 7895770
    [Abstract] [Full Text] [Related]

  • 5. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP, McColl SR, Braquet P, Borgeat P.
    Br J Pharmacol; 1994 Mar 15; 111(3):852-60. PubMed ID: 8019762
    [Abstract] [Full Text] [Related]

  • 6. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W, Javors MA, Olson MS.
    Arch Biochem Biophys; 1994 Feb 01; 308(2):439-45. PubMed ID: 8109973
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT, Payne JL, Goulet JL, Weller PF.
    J Exp Med; 1996 Apr 01; 183(4):1515-25. PubMed ID: 8666909
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
    Komatsu H, Amano M.
    Int J Immunopharmacol; 1997 Apr 01; 19(11-12):661-7. PubMed ID: 9669206
    [Abstract] [Full Text] [Related]

  • 9. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
    Hatzelmann A, Fruchtmann R, Mohrs KH, Raddatz S, Müller-Peddinghaus R.
    Biochem Pharmacol; 1994 Jul 05; 48(1):31-9. PubMed ID: 8043028
    [Abstract] [Full Text] [Related]

  • 10. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, Mantovani A.
    J Exp Med; 1995 Jun 01; 181(6):2181-6. PubMed ID: 7760005
    [Abstract] [Full Text] [Related]

  • 11. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar 01; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 12. Calcium ionophore potentiates chemotactic peptide and platelet activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
    Tanizawa H, Tai HH.
    Prostaglandins Leukot Essent Fatty Acids; 1990 May 01; 40(1):45-9. PubMed ID: 2169061
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
    Sisson JH, Prescott SM, McIntyre TM, Zimmerman GA.
    J Immunol; 1987 Jun 01; 138(11):3918-26. PubMed ID: 3035016
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G.
    J Allergy Clin Immunol; 1996 Jul 01; 98(1):152-64. PubMed ID: 8765829
    [Abstract] [Full Text] [Related]

  • 18. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
    Brom C, Brom J, König W.
    Immunology; 1991 Jul 01; 73(3):287-92. PubMed ID: 1652553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Leukotriene A4 modulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils.
    Hilger RA, König W.
    Immunology; 1992 Nov 01; 77(3):408-15. PubMed ID: 1335961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.